National Cancer Institute; Notice of Closed Meeting, 14805-14806 [E9-7308]
Download as PDF
Federal Register / Vol. 74, No. 61 / Wednesday, April 1, 2009 / Notices
fairness and evenhandedness in
judgment and review, ability to work
effectively in a group context,
commitment to complete work
assignments, adequacy of
representations of women, racial and
ethnic minority populations, and
geographic diversity.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Request for Nominations for AHRQ
Study Section Members
AGENCY: Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for nominations for
public members.
SUMMARY: In accordance with Title IX of
the Public Health Service Act, the
authorizing legislation for AHRQ and its
grant and contract regulations
pertaining to Peer Review of Grant and
Contracts 42 CFR Part 67, applications
submitted to the AHRQ will be
evaluated using the AHRQ peer review
process to ensure a fair, equitable, and
unbiased evaluation of their scientific
and technical merit. The initial peer
review of grant applications involves an
assessment conducted by panels of
experts established to include pertinent
scientific disciplines and medical
specialty areas. The confidential part of
the peer review meetings devoted to
critical evaluations will be closed
meetings in accordance with section
10(d) of the Federal Advisory
Committee Act as amended (5 U.S.C.,
Appendix 2).
AHRQ is seeking nominations to fill
approximately 20 to 30 percent of its
study section membership, across the
following study sections:
(1) Health System Research (HSR),
(2) Health Care Technology and
Decision Sciences (HCTDS),
(3) Health Care Quality and
Effectiveness Research (HCQER), and
(4) Health Care Research Training
(HCRT).
The primary research foci and
functions of these four study sections
are described on the AHRQ Web site
(https://www.ahrq.gov/fund/peerrev/
peerdesc.htm).
Individuals from the health services
research and health care community
who could serve as peer reviewers in
our study sections are sought to replace
study section members whose terms
have expired. In sending your
nomination, please specify the
nominee’s professional/scientific/
technical expertise, affiliations and full
contact information, if this information
is available.
Factors that will be considered in the
selection of individuals to serve on
study sections include: competence in a
scientific, technical or clinical
discipline or research specialty,
particularly in health services research,
VerDate Nov<24>2008
17:46 Mar 31, 2009
Jkt 217001
DATES: AHRQ would like to receive your
recommendations no later than Friday,
May 1, 2009.
Please direct your
correspondence to: Kishena C.
Wadhwani, PhD., M.P.H., Director,
Division of Scientific Review (DSR),
Office of Extramural Research,
Education and Priority Populations
(OEREP), Agency for Healthcare
Research and Quality (AHRQ),
Department of Health and Human
Services (DHHS), 540 Gaither Road,
Room 2032, Rockville, MD 20850,
Phone: (301) 427–1556, Fax: (301) 427–
1562, e-mail:
Kishena.Wadhwani@ahrq.hhs.gov.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Background
Currently, AHRQ has one chartered
Health Services Research Initial Review
Group (IRG) responsible for the peer
review of research and training grant
applications submitted for funding
consideration. The IRG is to advise the
Director of the Agency on matters
related to scientific and technical merit
of research grant proposals to improve
the quality, safety, efficiency, and
effectiveness of health care for all
Americans.
This IRG is currently comprised of
four subcommittees or study sections,
each with a particular research focus
around which peer reviewer’s expertise
is assembled. These study sections
convene three times per year to review
the grant applications submitted to the
three different submission cycles. Study
section members are appointed for up to
a maximum of four years.
Dated: March 24, 2009.
Carolyn M. Clancy,
AHRQ, Director.
[FR Doc. E9–7070 Filed 3–31–09; 8:45 am]
BILLING CODE 4160–90–P
PO 00000
14805
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
Notice of Cancellation: This notice
was published in the Federal Register
on March 19, 2009, Volume 74, Number
5, pages 813–814. The meeting
previously scheduled to convene on
March 31, 2009 has been cancelled.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton
Rd., NE., Mailstop: E–20, Atlanta, GA
30333, Telephone (513) 533–6800, Toll
Free 1–800–CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 26, 2009.
Andre Tyler,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–7268 Filed 3–31–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
A—Cancer Centers.
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\01APN1.SGM
01APN1
14806
Federal Register / Vol. 74, No. 61 / Wednesday, April 1, 2009 / Notices
Date: April 30–May 1, 2009.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Gail J. Bryant, MD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8107,
MSC 8328, Bethesda, MD 20892–8328, (301)
402–0801, gb30t@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7308 Filed 3–31–09; 8:45 am]
Date: April 9–10, 2009.
Time: 1 p.m.–5 p.m.
Agenda: To evaluate the Rapid Access to
Intervention Development Portfolio.
Place: National Institutes of Health,
Executive Plaza North, Conference Room H,
6130 Executive Boulevard, Rockville, MD
20852.
Contact Person: Phyllis G. Bryant,
Executive Secretary, Program Analyst,
Developmental Therapeutics Program,
National Cancer Institute, NIH, 6130
Executive Boulevard, Rm. 8022, Bethesda,
MD 20892, (301) 496–8720, pb45q@nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 25, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7312 Filed 3–31–09; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for preclinical
development resources for potential
new therapeutics for the treatment of
cancer. The outcome of the evaluation
will be a decision whether NCI should
support request(s) and make available
contract resources for development of
the potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Rapid
Access to Intervention Development.
VerDate Nov<24>2008
17:46 Mar 31, 2009
Jkt 217001
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Basic HIV Vaccine
Discovery Research (R01).
Date: April 29–May 1, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Sujata Vijh, PhD, Scientific
Review Officer, Scientific Review Program,
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–594–
0985, vijhs@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–7304 Filed 3–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NINDS Conference Grant
Review Panel.
Date: April 9, 2009.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, 3201, Rockville, MD 20852.
(Virtual Meeting).
Contact Person: Alan L. Willard, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20852–
9529. (301) 496–5390.
willarda@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
E:\FR\FM\01APN1.SGM
01APN1
Agencies
[Federal Register Volume 74, Number 61 (Wednesday, April 1, 2009)]
[Notices]
[Pages 14805-14806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-7308]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee A--Cancer Centers.
[[Page 14806]]
Date: April 30-May 1, 2009.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Gail J. Bryant, MD, Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Blvd., Room
8107, MSC 8328, Bethesda, MD 20892-8328, (301) 402-0801,
gb30t@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 26, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7308 Filed 3-31-09; 8:45 am]
BILLING CODE 4140-01-P